Source: Annual Congress 2012 - Paediatric bronchology
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Petreschi, T. Salerno, D. Peca, M.B. Chiarini Testa, A. Schiavino, M.G. Paglietti, O. Danhaive, R. Cutrera (Rome, Italy). A new mutation of surfactant protein C gene causing severe respiratory insufficiency and pulmonary fibrosis. Eur Respir J 2012; 40: Suppl. 56, 3342

Member's Comments

No comment yet.

Related content which might interest you: A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level Source: International Congress 2018 – Orphan diseases in children Year: 2018 Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias Source: Eur Respir J 2007; 29: 134-137 Year: 2007 Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004 Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001 Role of ABCA3 in paediatric interstitial lung disease associated with surfactant protein C gene mutations Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease Source: Eur Respir J, 54 (2) 1900388; 10.1183/13993003.00388-2019 Year: 2019 Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations Source: Eur Respir J 2014; 43: 638-641 Year: 2013 Surfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred Source: Eur Respir J 2011; 38: 861-869 Year: 2011 Comparison of pulmonary function and level of immunoglobulin E between tuberculous destroyed lung and chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 656s Year: 2005 Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult Source: Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019 Year: 2020 Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020 Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease? Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms Source: Eur Respir J 2002; 20: Suppl. 38, 529s Year: 2002 Elastin expression in very severe human COPD Source: Eur Respir J 2009; 33: 324-331 Year: 2009 Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Polymorphic variation in surfactant protein B is associated with COPD exacerbations Source: Eur Respir J 2008; 32: 938-944 Year: 2008 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Surfactant protein C mutations and familial pulmonary fibrosis: stuck in a loop on the scenic route Source: Eur Respir J, 59 (1) 2102147; 10.1183/13993003.02147-2021 Year: 2022